Literature DB >> 15774614

Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.

Zongdong Li1, Michael A Nardi, Simon Karpatkin.   

Abstract

Patients with early HIV-1 infection develop an autoimmune thrombocytopenia in which antibody is directed against an immunodominant epitope of the beta3 (glycoprotein IIIa [GPIIIa]) integrin, GPIIIa49-66. This antibody induces thrombocytopenia by a novel complement-independent mechanism in which platelets are fragmented by antibody-induced generation of H2O2 derived from the interaction of platelet nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and 12-lipoxygenase. To examine whether sharing of epitope between host and parasite may be responsible for this immunodominant epitope, we screened for antibody-reactive peptides capable of inhibiting platelet lysis and oxidation in vitro, using a filamentous phage display 7-mer peptide library. Fourteen of these phage-peptide clones were identified. Five shared close sequence similarity with GPIIIa49-66, as expected. Ten were molecular mimics with close sequence similarity to HIV-1 proteins nef, gag, env, and pol. Seven were synthesized as 10-mers from their known HIV-1 sequence and found to inhibit anti-GPIIIa49-66-induced platelet oxidation/fragmentation in vitro. Three rabbit antibodies raised against these peptides induced platelet oxidation/fragmentation in vitro and thrombocytopenia in vivo when passively transferred into mice. One of the peptides shared a known epitope region with HIV-1 protein nef and was derived from a variant region of the protein. These data provide strong support for molecular mimicry in HIV-1-immunologic thrombocytopenia within polymorphic regions of HIV-1 proteins. A known epitope of nef is particularly incriminated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15774614      PMCID: PMC1895171          DOI: 10.1182/blood-2005-01-0243

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

2.  The mechanism of thrombocytopenia in patients with HIV infection.

Authors:  Y Najean; J D Rain
Journal:  J Lab Clin Med       Date:  1994-03

3.  Thrombocytopenic purpura in narcotics addicts.

Authors:  S Savona; M A Nardi; E T Lennette; S Karpatkin
Journal:  Ann Intern Med       Date:  1985-06       Impact factor: 25.391

4.  Molecular mimicry between the trimeric ectodomain of the transmembrane protein of immunosuppressive lentiviruses (HIV-SIV-FIV) and interleukin 2.

Authors:  P F Serres
Journal:  C R Acad Sci III       Date:  2000-11

5.  Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura.

Authors:  A Bettaieb; P Fromont; F Louache; E Oksenhendler; W Vainchenker; N Duédari; P Bierling
Journal:  Blood       Date:  1992-07-01       Impact factor: 22.113

6.  Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.

Authors:  T Schneider; H P Harthus; P Hildebrandt; M Niedrig; M Bröker; W Weigelt; A Beck; G Pauli
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

7.  Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients.

Authors:  S Karpatkin; M A Nardi; K B Hymes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

8.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men.

Authors:  C M Walsh; M A Nardi; S Karpatkin
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

9.  Autoimmune thrombocytopenic purpura in homosexual men.

Authors:  L Morris; A Distenfeld; E Amorosi; S Karpatkin
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.

Authors:  M Nardi; S Karpatkin
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  38 in total

1.  A humanized single-chain variable fragment antibody against beta3 integrin in Escherichia coli.

Authors:  Suying Dang; Tao Hong; Bi-Sen Ding; Wei Zhang
Journal:  Hybridoma (Larchmt)       Date:  2011-12

Review 2.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

3.  HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

Authors:  John C Marecki; Carlyne D Cool; Jane E Parr; Virginia E Beckey; Paul A Luciw; Alice F Tarantal; Angela Carville; Richard P Shannon; Adela Cota-Gomez; Rubin M Tuder; Norbert F Voelkel; Sonia C Flores
Journal:  Am J Respir Crit Care Med       Date:  2006-05-25       Impact factor: 21.405

Review 4.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

Review 5.  Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.

Authors:  Davide Gibellini; Alberto Clò; Silvia Morini; Anna Miserocchi; Cristina Ponti; Maria Carla Re
Journal:  World J Virol       Date:  2013-05-12

6.  A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor microenvironment.

Authors:  Wei Zhang; Suying Dang; Tao Hong; Jian Tang; Jing Fan; Dawei Bu; Yanjie Sun; Zhugang Wang; Thomas Wisniewski
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

Review 7.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

8.  Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade.

Authors:  Kenneth E Sherman; Enass Abdel-Hameed; Susan D Rouster; Mohamed Tarek M Shata; Jason T Blackard; Parham Safaie; Barbara Kroner; Liliana Preiss; Paul S Horn; Shyam Kottilil
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

9.  C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke.

Authors:  Zongdong Li; Michael A Nardi; Yong-Sheng Li; Wei Zhang; Ruimin Pan; Suying Dang; Herman Yee; David Quartermain; Saran Jonas; Simon Karpatkin
Journal:  Blood       Date:  2009-02-13       Impact factor: 22.113

Review 10.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.